| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb12a064f514f0876c511fc78fbabcad |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate |
2018-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5160d00cf2c746591226147fa9f397cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea3261383858f99e1ac4c5a992fec877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4889c86be3f56d936106826da5d7e247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56ba6429b43d171ef947827388d2c45b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70c69e7edcb53c24d6f159b41b6b77c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9387bd86da4a6334cd5cecf49edc080 |
| publicationDate |
2020-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3638241-A4 |
| titleOfInvention |
PHARMACEUTICAL FORMULATIONS OF N- (2- (2- (DIMETHYLAMINO) ETHOXY) -4-METHOXY-5 - ((4- (1-METHYL-1H-INDOL-3-YL) PYRIMIDIN-2-YL) AMINO) PHENYL) ACRYLAMIDE AND SALT THEREOF |
| priorityDate |
2017-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |